Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79


How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes?

Martínez CH, Martin P, Chalasani V, Williams AK, Luke PP, Izawa JI, Chin JL, Stitt L, Pautler SE.

Can Urol Assoc J. 2011 Dec;5(6):E148-51. doi: 10.5489/cuaj.10035. Epub 2011 Mar 1.


Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.


Unclassified renal cell carcinoma: a report of 56 cases.

Lopez-Beltran A, Kirkali Z, Montironi R, Blanca A, Algaba F, Scarpelli M, Yorukoglu K, Hartmann A, Cheng L.

BJU Int. 2012 Sep;110(6):786-93. doi: 10.1111/j.1464-410X.2012.10934.x. Epub 2012 Mar 8.


Percutaneous cryoablation of solitary sporadic renal cell carcinomas.

Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Carter RE, Callstrom MR, Atwell TD.

BJU Int. 2012 Dec;110(11 Pt B):E526-31. doi: 10.1111/j.1464-410X.2012.11230.x. Epub 2012 May 15.


The Relationship between B7-H4 Expression and Clinicopathological Characteristics in Clinical Stage T1 Conventional Renal Cell Carcinoma.

Jung SG, Choi KU, Lee SD, Lee ZZ, Chung MK.

Korean J Urol. 2011 Feb;52(2):90-5. doi: 10.4111/kju.2011.52.2.90. Epub 2011 Feb 19.


Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA.

Eur Urol. 2013 Mar;63(3):486-92. doi: 10.1016/j.eururo.2012.08.062. Epub 2012 Sep 5.


Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?

Stec AA, Coons BJ, Chang SS, Cookson MS, Herrell SD, Smith JA Jr, Clark PE.

J Urol. 2008 Jun;179(6):2152-7. doi: 10.1016/j.juro.2008.01.111. Epub 2008 Apr 18.


Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.

Mitsuzuka K, Narita S, Koie T, Kaiho Y, Tsuchiya N, Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Habuchi T, Ohyama C, Arai Y.

BJU Int. 2013 May;111(6):914-20. doi: 10.1111/j.1464-410X.2012.11658.x. Epub 2013 Jan 15.


A novel prognostic model for patients with sarcomatoid renal cell carcinoma.

Zhang BY, Thompson RH, Lohse CM, Leibovich BC, Boorjian SA, Cheville JC, Costello BA.

BJU Int. 2015 Mar;115(3):405-11. doi: 10.1111/bju.12781. Epub 2014 Oct 19.


Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.

Raptis DA, Fessas C, Belasyse-Smith P, Kurzawinski TR.

Surgeon. 2010 Oct;8(5):239-46. doi: 10.1016/j.surge.2010.03.001. Epub 2010 Apr 2.


Impact of elective neck dissection vs observation on regional recurrence and survival in cN0-staged patients with squamous cell carcinomas of the upper aerodigestive tract.

Canis M, Plüquett S, Ihler F, Matthias C, Kron M, Steiner W.

Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):650-5. doi: 10.1001/archoto.2012.1026.


Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature.

Jewett M, Rendon R, Dranitsaris G, Drachenberg D, Tanguay S, Donnelly B, Fleshner N; Canadian surgical wait times (SWAT) initiative.

Can J Urol. 2006 Jun;13 Suppl 3:54-61. Review.


Prognostic role of tumour multifocality in renal cell carcinoma.

Siracusano S, Novara G, Antonelli A, Artibani W, Bertini R, Carini M, Carmignani G, Ciciliato S, Cunico SC, Lampropoulou N, Longo N, Martorana G, Minervini A, Mirone V, Simeone C, Simonato A, Valotto C, Zattoni F, Ficarra V; members of the SATURN Project - LUNA Foundation.

BJU Int. 2012 Dec;110(11 Pt B):E443-8. doi: 10.1111/j.1464-410X.2012.11121.x. Epub 2012 Apr 13.


Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.

Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS.

BJU Int. 2012 Oct;110(7):956-60. doi: 10.1111/j.1464-410X.2012.10937.x. Epub 2012 Feb 2.


Cancer of the penis--a review of 50 patients.

Heyns CF, van Vollenhoven P, Steenkamp JW, Allen FJ.

S Afr J Surg. 1997 Aug;35(3):120-4.


Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.

Shindo T, Masumori N, Kobayashi K, Fukuta F, Hirobe M, Tonooka A, Hasegawa T, Kitamura H, Tsukamoto T.

BJU Int. 2013 May;111(6):941-5. doi: 10.1111/j.1464-410X.2012.11771.x. Epub 2013 Jan 25.


Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.

Ramaswamy K, Kheterpal E, Pham H, Mohan S, Stifelman M, Taneja S, Huang WC.

Clin Genitourin Cancer. 2015 Aug;13(4):344-9. doi: 10.1016/j.clgc.2015.01.001. Epub 2015 Jan 22.


Lymph node dissection in renal cell carcinoma.

Capitanio U, Becker F, Blute ML, Mulders P, Patard JJ, Russo P, Studer UE, Van Poppel H.

Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13. Review.


Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.

Kim EH, Tanagho YS, Bhayani SB, Saad NE, Benway BM, Figenshau RS.

BJU Int. 2013 May;111(6):872-9. doi: 10.1111/j.1464-410X.2012.11432.x. Epub 2012 Nov 13.

Supplemental Content

Support Center